↓ Skip to main content

American Association for Cancer Research

Antitumor Activity of a Recombinant Soluble Ectodomain of Mutant Human Fibroblast Growth Factor Receptor-2 IIIc

Overview of attention for article published in Molecular Cancer Therapeutics, September 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
7 patents

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
14 Mendeley
Title
Antitumor Activity of a Recombinant Soluble Ectodomain of Mutant Human Fibroblast Growth Factor Receptor-2 IIIc
Published in
Molecular Cancer Therapeutics, September 2011
DOI 10.1158/1535-7163.mct-11-0163
Pubmed ID
Authors

Ju Wang, Xue-ting Liu, Hui Huang, Gang Xiao, Zhi-you Zhou, Yang Chen, Zhi-hong Yu, Shui-lian He, An-an Chen, Ding-ding Wang, Ying He, Zhi-cheng Zhang, An Hong

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 29%
Researcher 2 14%
Student > Doctoral Student 1 7%
Student > Bachelor 1 7%
Librarian 1 7%
Other 4 29%
Unknown 1 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 7 50%
Biochemistry, Genetics and Molecular Biology 2 14%
Sports and Recreations 1 7%
Energy 1 7%
Medicine and Dentistry 1 7%
Other 0 0%
Unknown 2 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2023.
All research outputs
#7,610,760
of 23,205,257 outputs
Outputs from Molecular Cancer Therapeutics
#1,689
of 3,889 outputs
Outputs of similar age
#44,161
of 126,737 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#22
of 45 outputs
Altmetric has tracked 23,205,257 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,889 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,737 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.